Urban One (NASDAQ:UONE – Get Free Report) issued its earnings results on Tuesday. The company reported $0.31 earnings per share (EPS) for the quarter, reports. Urban One had a negative net margin of 17.82% and a positive return on equity of 16.29%. The business had revenue of $110.39 million for the quarter.
Urban One Stock Performance
NASDAQ:UONE opened at $1.41 on Thursday. The business’s fifty day moving average is $1.63 and its 200 day moving average is $1.92. The firm has a market cap of $68.29 million, a price-to-earnings ratio of -0.83 and a beta of 0.92. The company has a debt-to-equity ratio of 2.54, a quick ratio of 2.76 and a current ratio of 2.77. Urban One has a 52-week low of $1.23 and a 52-week high of $4.55.
Insiders Place Their Bets
In other news, CFO Peter Thompson sold 200,000 shares of the company’s stock in a transaction dated Monday, September 23rd. The stock was sold at an average price of $1.23, for a total transaction of $246,000.00. Following the sale, the chief financial officer now directly owns 320,642 shares in the company, valued at $394,389.66. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 32.61% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Urban One Company Profile
Urban One, Inc, together with its subsidiaries, operates as an urban-oriented multi-media company in the United States. The company operates through four segments: Radio Broadcasting, Cable Television, Reach Media, and Digital. The Radio Broadcasting segment includes radio broadcasting operations that primarily target African-American and urban listeners.
Featured Stories
- Five stocks we like better than Urban One
- Insider Trading – What You Need to Know
- Can United States Cellular Ride Higher on Its Spectrum Strategy?
- 3 Small Caps With Big Return Potential
- HubSpot’s Growth in CRM: Can It Compete With Salesforce?
- Trading Halts Explained
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?”
Receive News & Ratings for Urban One Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Urban One and related companies with MarketBeat.com's FREE daily email newsletter.